Synmosa Biopharma (ROCO:4114) Short-Term Debt : NT$825 Mil (As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Short-Term Debt?

Synmosa Biopharma's Short-Term Debt for the quarter that ended in Sep. 2024 was NT$825 Mil.

Synmosa Biopharma's quarterly Short-Term Debt declined from Mar. 2024 (NT$1,215 Mil) to Jun. 2024 (NT$848 Mil) and declined from Jun. 2024 (NT$848 Mil) to Sep. 2024 (NT$825 Mil).

Synmosa Biopharma's annual Short-Term Debt increased from Dec. 2021 (NT$1,179 Mil) to Dec. 2022 (NT$1,185 Mil) but then declined from Dec. 2022 (NT$1,185 Mil) to Dec. 2023 (NT$958 Mil).

Synmosa Biopharma Short-Term Debt Historical Data

The historical data trend for Synmosa Biopharma's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma Short-Term Debt Chart

Synmosa Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

1,192.53

888.14

1,178.65

1,184.99

957.86

Synmosa Biopharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															1,053.19	957.86	1,215.44	847.93	825.21

Synmosa Biopharma Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Synmosa Biopharma Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Gongye 1st Road, Hukou Township, Hsinchu County, Hsinchu, TWN

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products, medical devices, cosmetics, animal drugs, chemical food additives, and beverages. It is also involved in manufacturing and sales, and environmental drugs wholesale (retail), as well as the import and export of related businesses. The company provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. The reporting segments of the company are; the Generic Drugs segment which derives key revenue, and the Active Pharmaceutical Ingredients segment.

Synmosa Biopharma Headlines

No Headlines